Dear Marijan,

I have already sent you list of participants for the meeting (April 10) and for the training.

The meeting with the representatives of NRA will be at 11:00 on 10^th of April about venue if you don’t mind we can arrange it at the Ministry.  Regarding the training if the participants should prepare “homework” I ask you to send me and I will distribute among them also please send me detailed information regarding training-  time and venue.

After mentioned meeting on 10^th of April we can meet with Deputy Minister if the schedule of experts will allow us.

Dear Marijan,

Please find below the list of participants for the meeting and for training

Day 1: April 10, 2018 (Tuesday) Meeting with key national stakeholders relevant to AEFI surveillance:

Participants from National Regulatory Agency:

1.       Naili Shengelidze, Head of Registration (MA) Division, Department of Pharmaceutical Activities;

2.       David Japaridze - Head of division of licenses at Department Of Pharmaceutical Activities;

3.       Nana Shanshiashvili -Head of division of inspection at Department Of Pharmaceutical Activities.

Day 3: April 12,2018 (Thursday) Training involving key national level counterparts involved in AEFI detection and Management:

4.       Nino Trokashvili - Chief Specialist of division of registration at Department Of Pharmaceutical Activities;

5.       Mariami Akhvlediani - Chief Specialist of division of registration at Department Of Pharmaceutical Activities.

If you have additional questions do not hesitate to contact me

Dear Sopo,

Please kindly find bellow the initial proposal for the programme for AEFI (Adverse Events Following Immunization) mission to be conducted during 10-13 April in Georgia.

·         1 day of meetings with key national stakeholders relevant to AEFI surveillance:

o   National Regulatory Agency, incl. a quick assessment at NRA (based on the pre-filled assessment questionnaire in the attachment and the interview during the meeting)

o   NCDC

·         1 day field visit (subnational district and health facility level), followed by work on consolidating findings and proposing a roadmap for strengthening AEFI surveillance

·         1-day training involving key national level counterparts involved in AEFI detection and management

o   Review the consolidating findings of assessment

o   Introduce new WHO concepts and tools related to AEFI surveillance

o   Discuss proposed roadmap and actions to strengthen AEFI surveillance in GEO

·         The last day to meet with National Steering Committee to review latest draft of updated AEFI surveillance guideline, and plan of action to finalize drafted guidelines, and discuss dates of training of updated guidelines in Q3/4.

The programme will be finalized once you confirm timing for the meeting with the NRA, which we propose to take place on day 1, 10 April, to discuss topics as follows:

AEFI reporting in Georgia, as well as the details of activities included in GAVI Transition Plan strengthening functions of the National Regulatory Authority (please see the table below):

We kindly ask you, to

-          secure the meeting with the NRA representatives (hopefully including you) as indicated above (10 April; please, define exact time and participants) and

-          secure presence of the NRA representative at the training (12 April).

The meetings with the NCDC, field visit, training and the meeting with the National Steering committee will be organized by us in close collaboration with the NCDC (which includes all respective logistics).

Thank you very much in advance.

Best regards,

Marijan Ivanusa

WHO Representative

Head of WHO Country Office Georgia

Office location: 81 Vasil Barnov Street, 0179 Tbilisi, Georgia

Mailing address: UN House, 9 Rapiel Eristavi Street, 0179 Tbilisi, Georgia

Mobile 1: +995 599 305 207

Mobile 2/EU/private: +386 40 528 639

Email: ivanusam@who.int

Skype: who-ivanusam

GPN: 74211

Web: www.euro.who.int